Skip to main content
MyCapitol LogoMyCapitol

HR 6483 · 117th Congress

Improved Transparency of Foreign Drug Manufacturing Act of 2022

Right now, when pharmaceutical companies make drugs overseas and ship them to the United States, there's a gap in what the government knows about where and how those drugs are actually being made. This bill closes that gap by requiring foreign drug manufacturers to register with the FDA and report detailed informati…

Sponsor
Eshoo, Anna G. (D-CA)
Introduced
2022-01-25
Policy area
Health
Latest action
Referred to the Subcommittee on Health.

Digging through Congress... 🔍